An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative

An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative

To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sarris, Kathy, Hutchins, Charles W, Li, Wenke, Carroll, William A, Patel, Sachel V, WOLLER, Kevin R, Randolph, John T, Jinkerson, Tammie K, Matulenko, Mark A, Krueger, Allan C, Degoey, David A, Betebenner, David A, Liu, Dachun, Tufano, Michael D, Kati, Warren M, Keddy, Ryan G, Flentge, Charles A, Maring, Clarence J, Pratt, John K, Bellizzi, Mary E, Hutchinson, Douglas K, Wagner, Rolf, Caspi, Daniel D, Rockway, Todd W, Donner, Pamela L, Califano, Jean C, Motter, Christopher E, Wagaw, Sebel H, Gao, Yi, Nelson, Lissa T
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Sarris, Kathy
Hutchins, Charles W
Li, Wenke
Carroll, William A
Patel, Sachel V
WOLLER, Kevin R
Randolph, John T
Jinkerson, Tammie K
Matulenko, Mark A
Krueger, Allan C
Degoey, David A
Betebenner, David A
Liu, Dachun
Tufano, Michael D
Kati, Warren M
Keddy, Ryan G
Flentge, Charles A
Maring, Clarence J
Pratt, John K
Bellizzi, Mary E
Hutchinson, Douglas K
Wagner, Rolf
Caspi, Daniel D
Rockway, Todd W
Donner, Pamela L
Califano, Jean C
Motter, Christopher E
Wagaw, Sebel H
Gao, Yi
Nelson, Lissa T
description To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ME02328B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ME02328B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ME02328B3</originalsourceid><addsrcrecordid>eNrjZHBzzFNIzCvJLMssSsxRMNRVKMhIzavM0VUw0jHVTclMSs2ryszNTEmsys_RNdUFShRUFhXl52SmZOalKqSkFmWWJQI1p_IwsKYl5hSn8kJpbgZZN9cQZw_d1IL8-NTigsTk1LzUknhfVwMjYyMLJ2NC8gACpDDV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative</title><source>esp@cenet</source><creator>Sarris, Kathy ; Hutchins, Charles W ; Li, Wenke ; Carroll, William A ; Patel, Sachel V ; WOLLER, Kevin R ; Randolph, John T ; Jinkerson, Tammie K ; Matulenko, Mark A ; Krueger, Allan C ; Degoey, David A ; Betebenner, David A ; Liu, Dachun ; Tufano, Michael D ; Kati, Warren M ; Keddy, Ryan G ; Flentge, Charles A ; Maring, Clarence J ; Pratt, John K ; Bellizzi, Mary E ; Hutchinson, Douglas K ; Wagner, Rolf ; Caspi, Daniel D ; Rockway, Todd W ; Donner, Pamela L ; Califano, Jean C ; Motter, Christopher E ; Wagaw, Sebel H ; Gao, Yi ; Nelson, Lissa T</creator><creatorcontrib>Sarris, Kathy ; Hutchins, Charles W ; Li, Wenke ; Carroll, William A ; Patel, Sachel V ; WOLLER, Kevin R ; Randolph, John T ; Jinkerson, Tammie K ; Matulenko, Mark A ; Krueger, Allan C ; Degoey, David A ; Betebenner, David A ; Liu, Dachun ; Tufano, Michael D ; Kati, Warren M ; Keddy, Ryan G ; Flentge, Charles A ; Maring, Clarence J ; Pratt, John K ; Bellizzi, Mary E ; Hutchinson, Douglas K ; Wagner, Rolf ; Caspi, Daniel D ; Rockway, Todd W ; Donner, Pamela L ; Califano, Jean C ; Motter, Christopher E ; Wagaw, Sebel H ; Gao, Yi ; Nelson, Lissa T</creatorcontrib><description>To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160620&amp;DB=EPODOC&amp;CC=ME&amp;NR=02328B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160620&amp;DB=EPODOC&amp;CC=ME&amp;NR=02328B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Sarris, Kathy</creatorcontrib><creatorcontrib>Hutchins, Charles W</creatorcontrib><creatorcontrib>Li, Wenke</creatorcontrib><creatorcontrib>Carroll, William A</creatorcontrib><creatorcontrib>Patel, Sachel V</creatorcontrib><creatorcontrib>WOLLER, Kevin R</creatorcontrib><creatorcontrib>Randolph, John T</creatorcontrib><creatorcontrib>Jinkerson, Tammie K</creatorcontrib><creatorcontrib>Matulenko, Mark A</creatorcontrib><creatorcontrib>Krueger, Allan C</creatorcontrib><creatorcontrib>Degoey, David A</creatorcontrib><creatorcontrib>Betebenner, David A</creatorcontrib><creatorcontrib>Liu, Dachun</creatorcontrib><creatorcontrib>Tufano, Michael D</creatorcontrib><creatorcontrib>Kati, Warren M</creatorcontrib><creatorcontrib>Keddy, Ryan G</creatorcontrib><creatorcontrib>Flentge, Charles A</creatorcontrib><creatorcontrib>Maring, Clarence J</creatorcontrib><creatorcontrib>Pratt, John K</creatorcontrib><creatorcontrib>Bellizzi, Mary E</creatorcontrib><creatorcontrib>Hutchinson, Douglas K</creatorcontrib><creatorcontrib>Wagner, Rolf</creatorcontrib><creatorcontrib>Caspi, Daniel D</creatorcontrib><creatorcontrib>Rockway, Todd W</creatorcontrib><creatorcontrib>Donner, Pamela L</creatorcontrib><creatorcontrib>Califano, Jean C</creatorcontrib><creatorcontrib>Motter, Christopher E</creatorcontrib><creatorcontrib>Wagaw, Sebel H</creatorcontrib><creatorcontrib>Gao, Yi</creatorcontrib><creatorcontrib>Nelson, Lissa T</creatorcontrib><title>An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative</title><description>To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBzzFNIzCvJLMssSsxRMNRVKMhIzavM0VUw0jHVTclMSs2ryszNTEmsys_RNdUFShRUFhXl52SmZOalKqSkFmWWJQI1p_IwsKYl5hSn8kJpbgZZN9cQZw_d1IL8-NTigsTk1LzUknhfVwMjYyMLJ2NC8gACpDDV</recordid><startdate>20160620</startdate><enddate>20160620</enddate><creator>Sarris, Kathy</creator><creator>Hutchins, Charles W</creator><creator>Li, Wenke</creator><creator>Carroll, William A</creator><creator>Patel, Sachel V</creator><creator>WOLLER, Kevin R</creator><creator>Randolph, John T</creator><creator>Jinkerson, Tammie K</creator><creator>Matulenko, Mark A</creator><creator>Krueger, Allan C</creator><creator>Degoey, David A</creator><creator>Betebenner, David A</creator><creator>Liu, Dachun</creator><creator>Tufano, Michael D</creator><creator>Kati, Warren M</creator><creator>Keddy, Ryan G</creator><creator>Flentge, Charles A</creator><creator>Maring, Clarence J</creator><creator>Pratt, John K</creator><creator>Bellizzi, Mary E</creator><creator>Hutchinson, Douglas K</creator><creator>Wagner, Rolf</creator><creator>Caspi, Daniel D</creator><creator>Rockway, Todd W</creator><creator>Donner, Pamela L</creator><creator>Califano, Jean C</creator><creator>Motter, Christopher E</creator><creator>Wagaw, Sebel H</creator><creator>Gao, Yi</creator><creator>Nelson, Lissa T</creator><scope>EVB</scope></search><sort><creationdate>20160620</creationdate><title>An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative</title><author>Sarris, Kathy ; Hutchins, Charles W ; Li, Wenke ; Carroll, William A ; Patel, Sachel V ; WOLLER, Kevin R ; Randolph, John T ; Jinkerson, Tammie K ; Matulenko, Mark A ; Krueger, Allan C ; Degoey, David A ; Betebenner, David A ; Liu, Dachun ; Tufano, Michael D ; Kati, Warren M ; Keddy, Ryan G ; Flentge, Charles A ; Maring, Clarence J ; Pratt, John K ; Bellizzi, Mary E ; Hutchinson, Douglas K ; Wagner, Rolf ; Caspi, Daniel D ; Rockway, Todd W ; Donner, Pamela L ; Califano, Jean C ; Motter, Christopher E ; Wagaw, Sebel H ; Gao, Yi ; Nelson, Lissa T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ME02328B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Sarris, Kathy</creatorcontrib><creatorcontrib>Hutchins, Charles W</creatorcontrib><creatorcontrib>Li, Wenke</creatorcontrib><creatorcontrib>Carroll, William A</creatorcontrib><creatorcontrib>Patel, Sachel V</creatorcontrib><creatorcontrib>WOLLER, Kevin R</creatorcontrib><creatorcontrib>Randolph, John T</creatorcontrib><creatorcontrib>Jinkerson, Tammie K</creatorcontrib><creatorcontrib>Matulenko, Mark A</creatorcontrib><creatorcontrib>Krueger, Allan C</creatorcontrib><creatorcontrib>Degoey, David A</creatorcontrib><creatorcontrib>Betebenner, David A</creatorcontrib><creatorcontrib>Liu, Dachun</creatorcontrib><creatorcontrib>Tufano, Michael D</creatorcontrib><creatorcontrib>Kati, Warren M</creatorcontrib><creatorcontrib>Keddy, Ryan G</creatorcontrib><creatorcontrib>Flentge, Charles A</creatorcontrib><creatorcontrib>Maring, Clarence J</creatorcontrib><creatorcontrib>Pratt, John K</creatorcontrib><creatorcontrib>Bellizzi, Mary E</creatorcontrib><creatorcontrib>Hutchinson, Douglas K</creatorcontrib><creatorcontrib>Wagner, Rolf</creatorcontrib><creatorcontrib>Caspi, Daniel D</creatorcontrib><creatorcontrib>Rockway, Todd W</creatorcontrib><creatorcontrib>Donner, Pamela L</creatorcontrib><creatorcontrib>Califano, Jean C</creatorcontrib><creatorcontrib>Motter, Christopher E</creatorcontrib><creatorcontrib>Wagaw, Sebel H</creatorcontrib><creatorcontrib>Gao, Yi</creatorcontrib><creatorcontrib>Nelson, Lissa T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Sarris, Kathy</au><au>Hutchins, Charles W</au><au>Li, Wenke</au><au>Carroll, William A</au><au>Patel, Sachel V</au><au>WOLLER, Kevin R</au><au>Randolph, John T</au><au>Jinkerson, Tammie K</au><au>Matulenko, Mark A</au><au>Krueger, Allan C</au><au>Degoey, David A</au><au>Betebenner, David A</au><au>Liu, Dachun</au><au>Tufano, Michael D</au><au>Kati, Warren M</au><au>Keddy, Ryan G</au><au>Flentge, Charles A</au><au>Maring, Clarence J</au><au>Pratt, John K</au><au>Bellizzi, Mary E</au><au>Hutchinson, Douglas K</au><au>Wagner, Rolf</au><au>Caspi, Daniel D</au><au>Rockway, Todd W</au><au>Donner, Pamela L</au><au>Califano, Jean C</au><au>Motter, Christopher E</au><au>Wagaw, Sebel H</au><au>Gao, Yi</au><au>Nelson, Lissa T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative</title><date>2016-06-20</date><risdate>2016</risdate><abstract>To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ME02328B
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title An antiviral 1- phenyl- 2,5-dibenzimidazol-5-yl-pyrrolidine derivative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T07%3A25%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Sarris,%20Kathy&rft.date=2016-06-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EME02328B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true